Pieter Jaap Gaillard
Gründer bei Mireca Medicines GmbH
Aktive Positionen von Pieter Jaap Gaillard
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Mireca Medicines GmbH
 Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Mireca Medicines GmbH develops treatment for hereditary eye disease. The company was founded by François Paquet-Durand, Pieter Jaap Gaillard and Barbara Brunnhuber in 2017 and is headquartered in Tubingen, | Vorsitzender | 01.04.2017 | - |
| Gründer | 01.01.2017 | - |
Karriereverlauf von Pieter Jaap Gaillard
Ehemalige bekannte Positionen von Pieter Jaap Gaillard
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | - |
| Gründer | 01.01.2003 | - |
Ausbildung von Pieter Jaap Gaillard
| University of Utrecht | Graduate Degree |
| University of Leiden | Doctorate Degree |
Statistik
International
| Niederlande | 4 |
| Deutschland | 2 |
Operativ
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
to-BBB technologies BV
to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
Mireca Medicines GmbH
Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Mireca Medicines GmbH develops treatment for hereditary eye disease. The company was founded by François Paquet-Durand, Pieter Jaap Gaillard and Barbara Brunnhuber in 2017 and is headquartered in Tubingen, | Health Technology |
- Börse
- Insiders
- Pieter Jaap Gaillard
- Erfahrung
